141 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
and potential equity financing opportunities. The Company believes these sources will be sufficient to cover the known short and long-term requirements
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
hair fibers. The anticipated long-term result of RCH-01 injections is the restoration and maintenance of a patient's hair.
Phase I Clinical Trial … primary objective was to provide a long-term safety profile of injections of cultured DSC cells five years after injection compared to control
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
and potential equity financing opportunities. The Company believes these sources will be sufficient to cover the known short and long-term requirements
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
. The anticipated long-term result of RCH-01 injections is the restoration and maintenance of a patient's hair.
Phase I Clinical Trial (Europe)
The primary … was to provide a long-term safety profile of injections of cultured DSC cells five years after injection compared to control. This objective was met
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
based company which provides independent pharmacies servicing long-term care and home care patients access to cost effective solutions. He … compensation strategy is to offer medium-term and long-term compensation components to ensure that the Company has in place programs to attract, retain
6-K
EX-99.1
y02pr hk6eqtlglc
9 Aug 23
Statement of Executive Compensation
7:41pm
6-K
EX-99.2
innmayz
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.1
ixqx d5jjs
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.2
liav34u4
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
8qapevq718p7j14
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
khlur3
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
zh1nukumgj6iqd5xsfu
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
tag59z
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.3
m10w7lt6
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.4
gglgxrkdzzizhdhe720u
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
n6sio
7 Jul 22
Statement of Executive Compensation
1:43pm
6-K
EX-99.1
umovyk83g4n2
30 Jun 22
Statement of Executive Compensation
11:16am
6-K
EX-99.1
x7ojvx39w jbzre
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm